Effectiveness of CoronaVac and BNT162b2 covid-19 mass vaccination in Colombia: a population-based cohort study

<p><strong>Background:</strong> In February 2021, Colombia began mass vaccination against COVID-19 using mainly BNT162b2 and CoronaVac vaccines. We aimed to estimate vaccine effectiveness (VE) to prevent COVID-19 symptomatic cases, hospitalization, critical care admission, and deat...

Full description

Bibliographic Details
Main Authors: Paternina-Caicedo, A, Jit, M, Alvis-Guzmán, N, Fernández, JC, Hernández, J, Paz-Wilches, JJ, Rojas-Suarez, J, Dueñas-Castell, C, Alvis-Zakzuk, NJ, Smith, A, De La Hoz-Restrepo, F
Format: Journal article
Language:English
Published: Elsevier 2022